The U.S. Department of Energy has selected two nuclear reactorsin New Mexico to produce molybdenum-99, the raw material for thecommonly used radioisotope technetium-99m. The move is an importantstep in a long effort by the agency to develop a U.S. source
The U.S. Department of Energy has selected two nuclear reactorsin New Mexico to produce molybdenum-99, the raw material for thecommonly used radioisotope technetium-99m. The move is an importantstep in a long effort by the agency to develop a U.S. source formolybdenum (SCAN 6/7/95).
The DOE hopes the project will provide an alternative to molybdenumdistributed by Canadian radioisotope firm Nordion Internationalof Kanata, Ontario. Nordion provides over 80% of the world's supplyof molybdenum, which is produced at a reactor operated by a Canadiangovernment agency (SCAN 7/17/96).
The DOE this month selected two sites, the Annular Core ResearchReactor and the Hot Cell Facility at Sandia National Laboratoriesin Albuquerque, and the Chemistry and Metallurgy Research Facilityat Los Alamos National Laboratory in Los Alamos, to produce molybdenum.The decision came after completion of an environmental impactstatement earlier this year.
The facilities should begin producing small quantities of molybdenumthis year, with production for medical uses beginning in 1997after Food and Drug Administration approval is granted. The DOEhopes to provide 10% of the U.S. supply of molybdenum next year,and believes the facilities could ultimately meet all of the U.S.needs for the radioisotope.
The DOE said it will encourage the privatization of molybdenumproduction. The New Mexico reactors are intended to ensure a reliablebackup supply of the isotope, and the DOE does not plan to competewith commercial radioisotope suppliers, the agency said.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.